Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 440-448

  Hardman, W E ^a   Moyer, M P ^a,b   Cameron, I L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b INCELL Corporation LLC ^*  (United States)

Author keywords

Breast cancer; CPT 11; Fish oil; Intestinal side effects; Irinotecan

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; FISH OIL; IRINOTECAN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER REGRESSION; CELL STRAIN MCF 7; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; GOBLET CELL; HUMAN; HUMAN CELL; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MITOSIS; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CAMPTOTHECIN; COLON; CORN OIL; DRUG SYNERGISM; DUODENUM; FEMALE; FISH OILS; GASTROINTESTINAL DISEASES; HUMANS; LIPID PEROXIDATION; MICE; MICE, NUDE; MUSCLE, SMOOTH; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032875203     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690713     Document Type: Article

References (30)

1. Abigerges D, Armand J-P, Chabol GG and et al (1994) Irinotecan (CPT-11) high-dose escalation using intensive high dose loperamide control diarrhea. J Natl Cancer Inst 86: 446-449
2. Anti M. Marra G, Armclao F, Bartoli GM, Ficarelli R, Percesepe A, De Vitis J, Maria G, Sofo L, Rapaccini GL, Gentiloni N, Piccioni E and Miggiano G (1992) Effect of Ω-3 Fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastro 103: 883 891
3. Barnes CJ, Lee M, Hardman WF, and Cameron JL (1997) NSAID modulation of colonic epithelial cell proliferation and apoptosis as intermediate biomarkers of induced rat colon cancer. Br J Cancer 77: 573 580
4. Bartram H, Gostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richter A and Kasper H (1993) Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2, release in healthy subjects. Gastro 105: 1317-1322
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
6. Cao S, Black JD, Troutt AB and Rustum YM (1998) Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res 58: 3270-3274
7. Colvin OM, Cokgor I, Ashley DM, Kerby T, Arbuck S, Malczyn J, Miller L, Cloughesy T, Houghton PJ, Rich J, Friedman AH and Friedman HS (1998) Irinotecan treatment of adults with recurrent or progressive malignant glioma. Proc Am Soc Clin Oncology 16: (Abstract)
8. Esterbauer H, Schaur RJ and Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 11: 81-128
9. Gerrits CJH, de Jonge MJA, Schellens JHM, Stoter G and Verweij J (1997) Topoisomerase 1 inhibitors: the relevance of prolonged exposure for present clinical development. Br J Cancer 76: 952-962
10. Hardman WE, Barnes, CJ, Knight CW and Cameron IL (1997) Effects of iron supplementation and ET-18-OCH, on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet. Br J Cancer 76: 347-354
11. Horrobin DF (1994) Unsaturated lipids and cancer. In: New Approaches to Cancer Treatment: Unsaturated lipids and Photodynamic Therapy, Horrobin DF (ed), pp. 3-29. Churchill Livingstone: London
12. Ikuno N, Soda H, Watanabe M and Oka M (1995) Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 87: 1876-1883
13. Kase Y, Hayakawa T, Aburada M, Komatsu Y and Kamataki T (1997a) Preventive effects of Hange-shashin-to an irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E, and water absorption in the rat. Jpn J Pharmacol 75: 407 413
14. 2 and water absorption of large intestine in rats. Jpn J Pharmacology 75: 399-405
15. Kawato Y, Aonuma M, Hirota Y, Kuga H and Sato K (1991) Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51: 4187-4191
16. Mosby's Complete Drug Reference 1997 Physicians GenRx-Drug Information, Atropine sulfate. II-175-II-177. Edited by Publisher: Ladig D. Mosby-Year Book: St Louis
17. Mosby's Complete Drug Reference 1997 Physicians GenRx-Drug Information, Loperamide hydrochloride. II-1286-II-1287. Edited by Publisher; Ladig D. Mosby-year Book; St. Louis
18. Narita M, Nagai E, Hagiwara H, Aburada M, Yokoi T and Kamataki T (1993) Inhibition of β-glucoronidase by natural glucuronides of kampo medicines using glucuronide of SN-38 (7-ethyl-10-hydroxycamptothecin) as a substrate. Xenobiotica 23: 5-10
19. Potten CS (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metast Rev 11: 179 195
20. Rivory LP (1996) Irinotecan (CPT-11): a brief overview. Clin and Exp Pharmacol and Physiol 23: 1000-1104
21. Rivory LP, Bowles MR, Robert J and Pond SM (1996) The conversion of CPT-11 (irinotecan) to its active metabolite. SN-38, by human liver carboxylesterase. Biochem Pharmacol 52: 1103-1111
22. Rothenberg M (1996) The current status of irinotecan (CPT-11) in the United States. Ann NY Acad Sci 803: 272-281
23. Sadzuka Y and Hirota S (1997) Effect of CPT-11 on lipid peroxidation level in mouse tissues. Jpn Y Cancer Res 88: 512-516
24. Sakai H, Diener M, Gartmann V and Takeguchi N (1995) Eicosanoid-mediated Cl secretion induced by the antitumor drug, irinotecan (CPT-11), in the rat colon. Naunyn-Schmiedeberg's Arch Pharmacol 351: 309-314
25. Sakai H, Sato T, Hamada N, Yasue M, Ikari A, Kakinoki B and Takeguchi N (1997) Thromboxane A, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl secretion in isolated rat colon. J Physiol 505.1: 133-144
26. Sawada S, Okajima S. Aiyama R, Nokota K, Furuta T, Yokokura T, Sugini E, Yamaguchi K and Miyasaka K (1991) Synthesis and antitumor activity of 20(S)-camptothecin derivatives. Carbamate linked, water-soluble derivatives of 7-ethyl-10-hydrocamptothecin. Chem Pharm Ball 39: 1446-1454
27. Shinohara H, Killion J, Kuniyasu H, Kumar R and Fidler IJ (1998) Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002. Clin Cancer Res 4: 2053-2063
28. Takasuna K, Kasai Y, Kitano Y, Kakihata K, Hirohashi M and Nomura M. (1995) Study on the mechanisms of diarrhea induced by a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11) in rats. Folia Pharmacol Jpn 105: 447-460
29. Takasuna K, Hagiwara T, Kato M, Namoru M, Nagai E, Yokoi T and Kamataki T (1996) Involvement of β-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res 56: 3752-3757
30. Weber PC and Sellmayer A (1990) Modification of the prostanoid system and cell signalling by precursor fatty acids. Adv Prostaglandin, Thrombox Leukotri Res 21: 217-224